Michael Kozal
Infectious Disease · Stanford, CANPI 1104899160
Payments from drug & device makers
What this record shows
That places this record below the midpoint for infectious disease clinicians in CA, where the typical reported total is $297.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$2,080,015in research payments, 2019–2025
Across 45 payments — averaging $46,223 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$2M
- Gilead$34K
How this compares
$0 in reported general payments places this provider in the 10th percentile of 856 infectious disease providers in California.
Other infectious disease in Stanford
- Paul EckburgStanford$98K
- Michael HarbourStanford$89K
- Philip GrantStanford$27K
- Claire PomeroySacramento$2.6M
- Javeed SiddiquiRoseville$1.5M
- George SakoulasSan Diego$902K
- Arthur JengSylmar$766K
- James McKinnellTorrance$762K
- Jay GladsteinLos Angeles$657K
- Tulika SinghOrange$654K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.